SH3BP5-high tumors displayed broad suppression of cycle activity, including priming and activation, immune cell recruitment (e.g., B cells and Treg cells), and the recognition of cancer cells by T cells (p < 0.05) (Fig. 7E-F). Here, SH3BP5 is linked to cancer.